An interventional study of Digital Support System for AIS Orthosis Wear and Conventional Treatment Control Group in Adolescent Idiopathic Scoliosis (AIS) and Adherence, sponsored by Shanghai Jiao Tong University School of Medicine. Recruiting at 1 site in China. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-07.
Sponsored by Shanghai Jiao Tong University School of Medicine · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 55 studies in Scoliosis with a site in China — 22 open to participants now, 26 under way, none of them phase 3. Scoliosis · China.
Among the 55 studies in Scoliosis with a site in China, this one is the 32nd largest by planned enrollment of the 37 interventional ones that give a count, is one of 5 that started in 2026, is one of 31 with no phase, reaches primary completion later than 9 of the 25 other live ones, and was the 53rd registered.
660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.
Browse Scoliosis studies →22 of the 55 studies in Scoliosis with a site in China are open now. Recruiting first, the newest first:
Peking Union Medical College Hospital · Sites in China
Ages 10–17
Second Affiliated Hospital of Wenzhou Medical University · Sites in China
Ages 10–15
Hangzhou Medical College · Sites in China
Ages 12–16
Peking Union Medical College Hospital · Sites in China
Ages 10–18
Second Affiliated Hospital of Wenzhou Medical University · Sites in China
Ages 6–15
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.
This study: 10 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
55 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 18 is below the median of 45 across 386 interventional studies indexed under Scoliosis.
Median enrollment 100 across the 37 interventional studies, 200 across the 18 observational. Of the 24 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 55 has an industry lead sponsor. The 10 most frequent:
Shanghai Jiao Tong University School of Medicine is the lead sponsor of 374 studies on the registry; 110 are open to participants now.
Shanghai Jiao Tong University School of Medicine has 1 study filed under Scoliosis — fewer than ten, so there is no comparison to draw.
10 of the studies in Scoliosis with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06314594Hangzhou Medical CollegeProtocol for a Randomized Controlled Trial of a Clinician-Supervised Home-School-Hospital-Linked Digital Health Platform-Supported Conservative Management Pathway for AIS | 2026-11-30 |
| NCT07899294Jiawei JiangConstruction of a Screening and Precision Intervention System for Adolescent Idiopathic Scoliosis Based on the DIERS Spinal Moiré System | 2026-12 |
| NCT06470165Xuanwu Hospital, BeijingPriority-Matching Correction Technique in Degenerative Lumbar Scoliosis | 2026-12-31 |
| NCT06728046West China HospitalErector Spinae Plane Block v.s Patient Controlled Analgesia in Correction Surgery for Idiopathic Scoliosis | 2026-12-31 |
| NCT06506227The First Affiliated Hospital of Zhejiang Chinese Medical UniversityResearch on Key Technologies for Risk Prediction and Precise Diagnosis and Treatment of AIS Based on Epigene-phenotype | 2026-12-31 |
Add all 10 to your calendar (.ics) → With an account.
Among the 55 studies in Scoliosis with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study focuses on improving the daily lives and treatment outcomes of teenagers diagnosed with Adolescent Idiopathic Scoliosis (AIS). For many young patients, wearing a corrective brace for 20+ hours a day is physically uncomfortable and psychologically challenging, leading to low compliance and emotional distress.The investigators have developed an integrated "Product System" designed to transform the bracing experience from a burdensome task into a guided, supportive journey. This system consists of three main components:Smart Sensing: Discrete, thin-film pressure sensors are integrated into the existing brace to monitor real-time wear time and fit quality without compromising comfort.Interactive Desktop Terminal: A dedicated device for the home that uses "narrative-driven" feedback (themed around a journey called "The Spine's Path"). Instead of cold medical data, it provides intuitive progress visualizations and rewards to keep participants engaged.Mobile Support App: A tool for both participants and parents to track long-term trends, access educational resources, and facilitate communication with healthcare providers.The Goal of the Study The primary objective is to evaluate how this digital intervention affects a participant's "Intrinsic Motivation"-the internal drive to adhere to treatment. By focusing on three psychological dimensions-Interest/Enjoyment, Perceived Competence, and Pressure/Tension-the investigators aim to determine if interactive feedback can reduce the "medical feel" of the brace and help teenagers feel more in control of the recovery.What Participation Involves Participants will use the product system during the daily routine in home and school environments. The investigators will collect objective data (brace usage hours) and subjective data (through the Intrinsic Motivation Inventory/IMI scale) to measure changes in behavior and mental well-being.Benefits for Families and ProvidersFor Participants: A more engaging, less stressful way to manage the condition and see real-time progress.For Families: Reduced friction regarding brace-wearing and better visibility into the participant's treatment status.For Healthcare Providers: Access to accurate, objective data on participant compliance, allowing for more personalized and effective clinical adjustments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of Adolescent Idiopathic Scoliosis (AIS).
Current orthotic treatment with a prescription for a spinal brace (e.g., Boston, Milwaukee, or similar corrective braces).
Between 10 and 18 years of age at the time of enrollment.
Ability to read, understand, and complete the Intrinsic Motivation Inventory (IMI) and other study-related questionnaires.
Access to a stable home environment with Wi-Fi or local network connectivity for the interactive desktop terminal.
Willingness of the participant to provide assent and the legal guardian to provide written .
Exclusion Criteria:
Secondary scoliosis caused by neuromuscular, congenital, or syndromic conditions (e.g., cerebral palsy or Marfan syndrome).
Scheduled spinal surgery within the planned study period.
Severe skin allergies or chronic dermatological conditions at the brace contact sites that might be aggravated by sensor integration.
Previous participation in similar digital intervention studies for scoliosis management.
Diagnosed cognitive impairments or severe psychological disorders that may interfere with accurate reporting or regular use of the product system.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm will use an integrated digital support system consisting of: Smart Monitoring: Thin-film pressure sensors integrated into the brace to automatically record daily wear time and pressure distribution. Interactive Terminal: A desktop device for the home that converts sensor data into "narrative-driven" feedback with rewards. Mobile App: A tool for patients and parents to track long-term trends, access educational content, and facilitate family interaction. Psychological Assessment: Participants will periodically complete the Intrinsic Motivation Inventory (IMI) to evaluate the system's impact on interest, competence, and pressure reduction.
Device: Digital Support System for AIS Orthosis Wear
Standard Care: Participants wear their conventional spinal braces according to their physician's prescription without any electronic monitoring or feedback devices. Manual Logging: Adherence data (daily wear time) is recorded manually by patients or parents through paper diaries or self-reporting during follow-ups. Routine Clinical Support: Participants receive standard medical education and attend scheduled physical examinations and adjustments.
Behavioral: Conventional Treatment Control Group
Smart Monitoring: Thin-film pressure sensors integrated into the brace to automatically record daily wear time and pressure distribution. Interactive Terminal: A desktop device for the home that converts sensor data into "narrative-driven" feedback (e.g., "The Spine's Path") with rewards. Mobile App: A tool for patients and parents to track long-term trends, access educational content, and facilitate family interaction. Psychological Assessment: Participants will periodically complete the Intrinsic Motivation Inventory (IMI) to evaluate the system's impact on interest, competence, and pressure reduction.
Standard Care: Participants wear their conventional spinal braces according to their physician's prescription without any electronic monitoring or feedback devices. Manual Logging: Adherence data (daily wear time) is recorded manually by patients or parents through paper diaries or self-reporting during follow-ups. Routine Clinical Support: Participants receive standard medical education and attend scheduled physical examinations and adjustments.
Orthosis Wearing Compliance (Brace Adherence)
The average daily wear time of the scoliosis brace, automatically recorded by the integrated pressure sensors. Compliance is calculated as the percentage of actual wear time versus the physician-recommended duration.
Time frame: 4 weeks
Intrinsic Motivation Score (IMI)
Changes in the patient's intrinsic motivation levels as measured by the Intrinsic Motivation Inventory (IMI). This includes three specific sub-scales: Interest/Enjoyment, Perceived Competence, and Pressure/Tension (using a 7-point Likert scale).
Time frame: 4 weeks
Plan to share: No — IPD will not be shared to ensure the privacy and confidentiality of the minor participants. Data access is restricted to the primary research team for the purposes of the specified study protocol.
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Jul 2026, 5 months after the start.
Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 5 months is below that.
Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Jiao Tong University School of Medicine →